Vera Therapeutics (VERA) Total Non-Current Liabilities (2020 - 2026)
Vera Therapeutics' (VERA) quarterly Total Non-Current Liabilities came in at $120.2 million in Q1 2026, down 6.33% on a QoQ basis from $128.3 million in Q4 2025.
Powered by 
Analysis
Vera Therapeutics (VERA) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends
Vera Therapeutics (VERA) has 2 years of Total Non-Current Liabilities data on file, last reported at $120.2 million in Q1 2026.
- Quarterly Total Non-Current Liabilities changed N/A year-over-year to $120.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $120.2 million (changed N/A YoY) and the FY2025 annual result came in at $128.3 million, changed N/A from the prior year.
- Total Non-Current Liabilities eased to $120.2 million in Q1 2026, from $128.3 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $128.3 million in Q4 2025 to a low of $120.2 million in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 5.92 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 7.74 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 40.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 3.92 Bn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 1.53 Bn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 1.88 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 4.20 Bn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 9.32 Bn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 1.17 Bn |
| 10 | Vera Therapeutics | 2.58 Bn | 2.58 Bn | - | 123.55 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 123.55 Mn |
| Mar 31, 2026 | 120.18 Mn |
| Dec 31, 2025 | 128.29 Mn |
| Dec 31, 2024 | 78.53 Mn |
| Sep 30, 2024 | 79.50 Mn |
| Jun 30, 2024 | 69.14 Mn |
| Mar 31, 2024 | 65.53 Mn |
| Dec 31, 2023 | 73.58 Mn |
| Sep 30, 2023 | 51.63 Mn |
| Jun 30, 2023 | 54.37 Mn |
| Mar 31, 2023 | 51.61 Mn |
| Dec 31, 2022 | 54.24 Mn |
| Sep 30, 2022 | 25.37 Mn |
| Jun 30, 2022 | 26.99 Mn |
| Mar 31, 2022 | 30.26 Mn |
| Dec 31, 2021 | 13.87 Mn |
| Sep 30, 2021 | 5.40 Mn |
| Jun 30, 2021 | 5.21 Mn |
| Mar 31, 2021 | 5.28 Mn |
| Dec 31, 2020 | 4.04 Mn |